A randomized, placebo-controlled trial of quetiapine (Seroquel) monotherapy in the treatment of PTSD [Post-Traumatic Stress Disorder]

Trial Profile

A randomized, placebo-controlled trial of quetiapine (Seroquel) monotherapy in the treatment of PTSD [Post-Traumatic Stress Disorder]

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jul 2016 Results published in the American Journal of Psychiatry (2016).
    • 15 Sep 2009 Results presented at the 22nd Annual Congress of the European College of Neuropsychopharmacology.
    • 26 Feb 2008 The expected completion date for this trial is now 1 Dec 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top